Tackling mPDAC: chemotherapy strategies that matter

May 19, 2025 00:21:51
Tackling mPDAC: chemotherapy strategies that matter
COR2ED - Oncology Medical Conversation
Tackling mPDAC: chemotherapy strategies that matter

May 19 2025 | 00:21:51

/

Show Notes

Metastatic pancreatic ductal adenocarcinoma (mPDAC) is notoriously aggressive with a poor prognosis. It is often diagnosed late, and by this time, surgery is usually not an option. Median overall survival without treatment is just a few months but with systemic chemotherapy this can be improved.   

This video includes the highlights from a video podcast where medical oncologists Prof Shubham Pant and Prof Efrat Dotan discuss how to choose and optimise the different chemotherapeutic options at first and second line. 

Key clinical takeaways: 

You can also watch a video of the experts in conversation and download the accompanying transcript on our website: https://cor2ed.com/gi-connect/programmes/tackling-mpdac/?media=0 

Or watch on YouTube: https://youtu.be/8YxRnjOYUv4 

Follow us on social media: 

LinkedIn: https://www.linkedin.com/company/giconnect 

X: https://x.com/giconnectInfo 

This content is intended for healthcare professionals only. 

The medical experts in this podcast are expressing their own views and not those of COR2ED, Supporters or their institution.  This podcast is supported by an Independent Education Grant from Ipsen USA. 

This podcast is developed by cor2ed.com 

Published May 2025 

Subscribe to this channel to stay up to date with new Independent Education programmes as they’re released.

Other Episodes

Episode

December 06, 2023 00:30:22
Episode Cover

HCC: Updates from ILCA and ESMO 2022

In this HCC CONNECT podcast HCC Experts Prof. Matthias Pinter and Prof. Jeroen Dekervel, discuss and debate the clinical implications of new HCC Phase...

Listen

Episode

December 06, 2023 00:20:49
Episode Cover

RCC: Treating advanced RCC - The role of VEGFR-TKIs alone or in combination therapy

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Prof. Georg Hutterer, a Urologist from the Medical University of...

Listen

Episode

December 06, 2023 00:26:43
Episode Cover

Prostate cancer: PARP inhibitors in prostate cancer

COR2ED Medical Education: Dr Jason Alcorn, nurse consultant for Uro-Oncology & Andrology at the Mid Yorkshire Hospitals NHS Trust, United Kingdom and Dr Alicia...

Listen